NKGEN Biotech

NKGen Biotech is a clinical-stage biotechnology company focused on developing and commercializing innovative autologous, allogeneic, and CAR-NK natural killer cell therapies using our proprietary SNK (Supercharged Natural Killer) platform. Leading our industry-disrupting technology are our senior leadership, senior advisors, and management team, who together bring extensive knowledge and expertise in the field of immuno-oncology, and are passionate and excited about our work to enhance the immune system.